Following FDA approval of a single-tablet bictegravir, emtricitabine, and tenofovir alafenamide regimen for use in adults with HIV, investigators are exploring the safety and efficacy of the same therapy in children and adolescents aged 6 to 18 years.
Weight gain is often a concern for patients on ART. But what about the metabolic impact of PrEP on HIV-uninfected individuals?
DOLPHIN-2 reports that dolutegravir is well-tolerated and achieves more rapid virological suppression prior to delivery compared to efavirenz when initiated during pregnancy.
Bacterial sexually transmitted infections are still prevalent among men who have sex with men in England, but PrEP and other measures have sharply cut the rate of new HIV diagnoses.
A trial comparing raltegravir with efavirenz for antiretroviral therapy in treatment naïve pregnant women with HIV supports the use of raltegravir, especially for women starting ART later in gestation.
Prior studies have indicated that patients with influenza A infections fare worse than those with influenza B, and now a new study backs it up.
Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, has been fighting HIV/AIDS since the 1980s when the virus was first discovered. Now, thanks to a joint effort by multiple arms of the US Department of Health and Human Services, he’s making headway.
Investigators from England report the longest adult HIV remission observed since the Berlin patient.
Over a 12-month study, there was a 13.9% increase of retention with viral load suppression among participants who received rapid viral load results following point-of-care testing.
Vaccine-preventable disease outbreaks are on the rise and social media has a responsibility to help rein it in
Investigators in Denmark showed that a cocktail of common antibiotics could fight resistant E coli and treat urinary tract infections after determining that resistance toward 1 drug leads to sensitivity to another.
Recognizing that many college students are in the riskiest category, agewise, for HIV, new guidelines aim to help providers be more proactive about PrEP.
Influenza vaccines may be less effective in older adults due to a lack of antibody diversity, a new study suggests.
We’ve rounded up a list of important US Food and Drug Administration and US Department of Agriculture recalls from this past week.
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
Although influenza A H1N1 continues to dominate the current flu season in the US, H3N2 viruses are on the rise in some parts of the country.
Violence in the Democratic Republic of Congo has complicated public health efforts and overshadowed strides made in the response to the Ebola outbreak there.
T2 Biosystems, Inc. received FDA Breakthrough Device Designation for its T2Resistane Panel, a new device to aid in the fight against antimicrobial resistance.
Using genome sequencing, investigators have been able to identify clusters of individuals with HIV—with a particular focus on transgender women.
Powassan virus counts in the United States have been on the rise over the last decade, and now a new study sheds light on how ticks rapidly transmit the rare disease.
Women in the South look to family planning providers for more information about HIV PrEP, according a recent study in the journal Contraception.
The Contagion® editorial staff will be providing exclusive written and video coverage from CROI 2019.
State health care-associated infection reporting laws are critical for surveillance, but are they bogging down infection prevention programs?
With 6 ongoing outbreaks, cases reported across 10 states, and the FDA commissioner contemplating federal intervention, measles remains at the forefront of collective consciousness.
UK study in Addiction identifies benefits for controversial programs proposed as a solution for the ongoing opioid crisis.
Workers in a variety of industries—not just health care—face significant risk of infection at work. A new study finds a number of new risks are emerging, adding to the need for vigilance.
Spero Therapeutics announced that SPR720, an oral agent being developed for the treatment of lung infections caused by NTM, has received QIDP designation from the FDA.
Mycobacterium avium isolates were detected in household water in 81.1% of households sampled in a new study, suggesting a link to Mycobacterium avium complex lung disease.
#ICYMI, here are the highlights from Contagion®'s first-ever TweetChat on Treating Gram-Negative Infections in the Era of Resistance.
Investigators at Memorial Sloan Kettering Cancer Center determined valganciclovir was the preferred first-line preemptive therapy to prevent cytomegalovirus in patients following an allogeneic hematopoietic cell transplantation.